Updated Results From a Phase I Study of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study @KidneyCancer - 100098

Spotlight
Video

Updated Results From a Phase I Study of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study @KidneyCancer

kidneycancer has 583 videos Subscribe Here

Loading........
Description: Hans J. Hammers, MD of the University of Texas Southwestern Medical Center discusses Updated Results From a Phase I Study of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study from the  12th European International Kidney Cancer Symposium 2017
Shared By : kidneycancer
Posted on : 04/25/17
Added : 2 years ago
Category : Kidney Cancer